Pharmatraxate 2.5 Tab

Doctors typically prescribe it as a single weekly dose rather than daily, since dosing errors can be dangerous.

Pharmatraxate 2.5mg Tablet Ingredients and Usage

Pharmatraxate 2.5mg Tablet contains methotrexate, an antimetabolite belonging to the folic acid antagonist drug class. Doctors prescribe it for rheumatoid arthritis and severe psoriasis, where it reduces inflammation and slows disease progression.

At higher doses under oncologist supervision, Pharmatraxate 2.5mg Tablet treats leukemia, lymphoma, and gestational trophoblastic disease. Rheumatologists also use it for lupus and certain forms of vasculitis, typically as a once weekly dose rather than a daily one.

How Does Pharmatraxate 2.5mg Tablet Work?

Methotrexate inhibits dihydrofolate reductase, an enzyme that converts dihydrofolate into tetrahydrofolate. Tetrahydrofolate is essential for synthesizing purines and thymidylate, the building blocks needed for DNA replication.

By blocking this pathway, Pharmatraxate 2.5mg Tablet slows the growth of rapidly dividing cells, including cancer cells and the inflammatory cells that drive autoimmune joint damage. In cancer, this leads to tumor cell death; in arthritis and psoriasis, it dampens the abnormal immune response.

Pharmatraxate 2.5mg Tablet Side Effects

Pharmatraxate 2.5mg Tablet commonly causes digestive and general side effects, particularly at higher doses. Folic acid supplementation often reduces these effects.

• Nausea and vomiting

• Mouth sores

• Fatigue

• Loss of appetite

• Hair thinning

• Increased sensitivity to sunlight

• Headache

Warnings

• Pharmatraxate 2.5mg Tablet is dosed weekly for arthritis and psoriasis; taking it daily by mistake can cause fatal toxicity, so confirm the schedule with a pharmacist before starting.

• The medicine is strictly contraindicated in pregnancy, especially in the first trimester, as it can cause severe fetal harm.

• Avoid alcohol during treatment, since methotrexate increases the risk of liver toxicity; regular liver function monitoring is required.

• Pharmatraxate 2.5mg Tablet can cause bone marrow suppression, leading to low blood cell counts; routine blood tests are necessary throughout treatment.

• Do not use in patients with severe liver or kidney disease, active infection, or pre-existing low blood counts.

• Avoid live vaccines during therapy, since methotrexate weakens the immune response and raises infection risk.

• Nonsteroidal anti-inflammatory drugs and certain antibiotics can increase methotrexate toxicity; inform the doctor of all other medications.

Pharmatraxate 2.5mg Tablet Storage Conditions

Store Pharmatraxate 2.5mg Tablet at room temperature, away from direct heat and moisture. Keep tablets in their original packaging and avoid refrigeration. Store this medicine out of reach of children, and dispose of any unused or expired tablets according to local pharmacy guidelines.